The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,042.00
Bid: 12,042.00
Ask: 12,044.00
Change: -114.00 (-0.94%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,098.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Ghana kicks off coronavirus vaccination campaign with COVAX shots

Tue, 02nd Mar 2021 15:21

* President says Ghana to inoculate 20 million people by
year-end

* COVAX vaccines scheme accelerates deliveries

* Nigeria, Angola, Congo receive COVAX vaccines on Tuesday
(Adds detail on rollout, drone delivery)

By Christian Akorlie

ACCRA, March 2 (Reuters) - Ghana launched its coronavirus
vaccination drive on Tuesday after receiving 600,000 AstraZeneca
doses from the global COVAX vaccine-sharing scheme aimed
at helping developing nations combat the pandemic.

The start of vaccinations in Ghana, and in neighbouring
Ivory Coast on Monday, and the expected delivery of millions of
vaccines from the COVAX programme this week will enable more
poor countries to start inoculating mostly frontline workers and
the most vulnerable, months after wealthier countries began.

COVAX is the programme backed by the World Health
Organization and GAVI vaccine alliance to provide vaccines for
poor and middle-income countries. It said on Tuesday it aims to
deliver 237 million doses of AstraZeneca's shot to 142 countries
by the end of May as it steps up the global rollout.

On Tuesday, Nigeria took delivery of 3.92 million doses of
the Oxford/AstraZeneca vaccine, while Angola received 624,000.
Democratic Republic of Congo is readying for a COVAX delivery
later on Tuesday and Senegal expects 324,000 doses from the
scheme on Wednesday.

Ghanaian President Nana Akufo-Addo said the West African
country aimed to vaccinate 20 million people, or over 66% of its
population, by the end of 2021.

People lined up outside the regional hospital in the
capital, Accra, for a first phase of vaccinations which will
prioritise frontline health workers and others at high risk.

"I feel so good about taking the vaccine. It will protect me
from contracting the virus from patients," said Bernice
Anaglatey, 42, who works in the COVID-19 intensive care unit at
Accra's Ridge Hospital as she queued for her shot.

Drones from U.S.-based startup Zipline delivered some of the
vaccines to Ghanaian health facilities, making the country the
first in the world to use the technology on a national scale to
deliver COVID-19 shots, the company said.

Ghana was also the first country to receive the vaccines
under COVAX, which aims to distribute more than 1.3 billion
vaccine doses to over 90 low- and middle-income countries by the
end of the year, covering up to 20% of their populations.

Only a handful of other African countries have started
inoculations, with doses bought bilaterally or received as
donations.

Vaccine deliveries through the COVAX scheme are expected to
accelerate this week with 11 million doses of AstraZeneca and
Pfizer-BioNTech vaccines.

Health authorities are also stepping up efforts to fight
conspiracy theories around the vaccines. President Akufo-Addo
and his wife were inoculated on Monday in an effort to boost
public confidence in the vaccines. nL5N2KY0W2]

"The stories I heard about the vaccine have put fear in me,"
said Isaac Armah, a 28-year-old trader in Accra. "I'll wait for
about two months to see the effects of the vaccine on the early
recipients, then I'll make up my mind."

Coronavirus infections in Ghana have surpassed 84,000 and
more than 600 people have died, according to health ministry
data.

(Reporting by Christian Akorlie, Writing by Nellie Peyton and
Alessandra Prentice;
Editing by Bate Felix, Emelia Sithole-Matarise and Nick Macfie)

More News
Today 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.